|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Johns Hopkins University (Drs. Nogee, Dunbar, and Askin), Baltimore, MD; University of Cincinnati (Drs. Wert and Whitsett), Cincinnati, OH; and Washington University (Dr. Hamvas), St. Louis, MO.
Correspondence to: Lawrence M. Nogee, MD, Division of Neonatology, CMSC 6-104, Johns Hopkins Hospital, 600 N. Wolfe St, Baltimore, MD 21287
The molecular basis for most forms of interstitial lung disease (ILD) is unknown. We recently identified a splicing mutation (c.460 + 1G > A) in the gene encoding surfactant protein C (SP-C) in two affected individuals with familial ILD.1 To test the hypothesis that SP-C mutations cause both sporadic and familial lung disease, we analyzed the SP-C gene sequence in infants with chronic lung diseases of unknown etiology. Mutations on one allele of the SP-C gene were identified in 11 of 34 patients evaluated. One infant had a mutation in the same location, but with a different nucleotide substitution (G > T) as the patients with the c.460 + 1G > A mutation. The clinical, histopathologic, and biochemical findings of these patients were similar, and included skipping of exon 4, expression of an aberrantly migrating proprotein corresponding to the size of the deletion, and reduced amounts of normal pro-SP-C. However, neither parent had a history of lung disease or carried the mutation. The occurrence of a de novo mutation functionally identical to a familial mutation in infants with the same phenotype strongly supports the hypothesis that the mutations were causally related to their lung disease. Missense SP-C mutations that resulted in amino-acid substitutions in residues highly conserved across species (P30 L, I73T, G100V, Y104H, P115 L, I126R, T187N, and L188R), as well as a frameshift mutation (140delA) associated with expression of a stable transcript, were identified in 10 other infants, 6 of whom had a family history of lung disease. None of the identified mutations were found on 100 control chromosomes, indicating that they are not common polymorphisms. We conclude that mutations in the SP-C gene are a cause of both familial and sporadic ILD. While the pathophysiologic mechanisms remain to be elucidated, the finding of mutations on one allele suggests a dominant negative effect on SP-C or pro-SP-C function or metabolism.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Johansson, K. Nordling, T. E. Weaver, and J. Johansson The Brichos Domain-containing C-terminal Part of Pro-surfactant Protein C Binds to an Unfolded Poly-Val Transmembrane Segment J. Biol. Chem., July 28, 2006; 281(30): 21032 - 21039. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Lawson and J. E. Loyd The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proceedings of the ATS, January 1, 2006; 3(4): 345 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Lawson, V. V. Polosukhin, G. T. Stathopoulos, O. Zoia, W. Han, K. B. Lane, B. Li, E. F. Donnelly, G. E. Holburn, K. G. Lewis, et al. Increased and Prolonged Pulmonary Fibrosis in Surfactant Protein C-Deficient Mice Following Intratracheal Bleomycin Am. J. Pathol., November 1, 2005; 167(5): 1267 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Deterding and L. L. Fan Surfactant Dysfunction Mutations in Children's Interstitial Lung Disease and Beyond Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 940 - 941. [Full Text] [PDF] |
||||
![]() |
J. E. Bullard, S. E. Wert, J. A. Whitsett, M. Dean, and L. M. Nogee ABCA3 Mutations Associated with Pediatric Interstitial Lung Disease Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1026 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. W. Yang, J. C. Weissler, L. S. Terada, F. Deng, and Y.-S. Yang Pleiomorphic Adenoma Gene-Like-2, a Zinc Finger Protein, Transactivates the Surfactant Protein-C Promoter Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bush Paediatric interstitial lung disease: not just kid's stuff Eur. Respir. J., October 1, 2004; 24(4): 521 - 523. [Full Text] [PDF] |
||||
![]() |
A. Hamvas, L. M. Nogee, F. V. White, P. Schuler, B. P. Hackett, C. B. Huddleston, E. N. Mendeloff, F.-F. Hsu, S. E. Wert, L. W. Gonzales, et al. Progressive Lung Disease and Surfactant Dysfunction with a Deletion in Surfactant Protein C Gene Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Glasser, E. A. Detmer, M. Ikegami, C.-L. Na, M. T. Stahlman, and J. A. Whitsett Pneumonitis and Emphysema in sp-C Gene Targeted Mice J. Biol. Chem., April 11, 2003; 278(16): 14291 - 14298. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Wang, S. Mulugeta, S. J. Russo, and M. F. Beers Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative J. Cell Sci., February 15, 2003; 116(4): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Q. Thomas, K. Lane, J. Phillips III, M. Prince, C. Markin, M. Speer, D. A. Schwartz, R. Gaddipati, A. Marney, J. Johnson, et al. Heterozygosity for a Surfactant Protein C Gene Mutation Associated with Usual Interstitial Pneumonitis and Cellular Nonspecific Interstitial Pneumonitis in One Kindred Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1322 - 1328. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |